Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
about
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthLong-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Childhood mastocytosis: results of a single center.Mastocytosis: pathology, genetics, and current options for therapy.The serum tryptase test: an emerging robust biomarker in clinical hematology.Systemic mastocytosis: bone marrow pathology, classification, and current therapies.Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathwaySynergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816VAssessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosisAdverse reactions associated with acetylcysteine.Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case review.Advanced imaging of skeletal manifestations of systemic mastocytosis.European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.Indolent systemic mastocytosis limited to the bone: a case report and review of the literature.Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disordersSystemic mastocytosis - a diagnostic challengeGene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia.Transient hypogammaglobulinaemia of infants in children with mastocytosis - strengthened indications for vaccinations.Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM)Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression.Abnormal bone marrow histopathology in paediatric mastocytosis.Mastocytosis in children and adults: clinical disease heterogeneitySystemic Mastocytosis Causing Refractory Pruritus in a Liver Disease Patient.Localized eosinophilic ileitis with mastocytosis successfully treated with oral budesonide.Midostaurin: a magic bullet that blocks mast cell expansion and activation.Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay.Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience.Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells.How reliable is blood tryptase as a marker of systemic disease in an infant with cutaneous mastocytomas?Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.
P2860
Q28828739-F4A8A7DF-82A2-47D8-9946-509B1D9386DFQ35153623-2D8E5D16-D855-4EEF-B694-3B1B99E76EC0Q35913666-F1183307-5B83-4841-8D45-0ABEB8BAC8FBQ35994902-3F9D5925-F519-4C27-BE80-C304A7B2322AQ36154674-97D88BE6-89D8-4452-A439-B342EC56A74FQ36182749-BC00A97E-4CA1-401D-93F3-B81A0BC97D47Q36406996-792B3449-A3A0-45BF-B550-C645A11670AFQ37103894-D4A78E78-20FF-49F6-87DA-90C45794FAB4Q37144902-EEBD0B11-9D6A-476A-B35F-EF05D673851BQ37174205-15A2B6F3-2458-448D-B30F-DD9C5A9E4B98Q37413080-0CCAD1E3-CC13-4483-904A-AE644186B3ACQ37955869-687DDD7C-4373-4E89-8D4C-78AB24B46E1EQ37988308-85679406-D17B-4F8B-884B-E6F204F2F1B2Q38062360-BD55D467-56DC-44D8-B484-431A17F430E8Q38125573-77FFC4D7-BC18-4C38-8D69-617AD2CD2FDDQ38193659-F5241FF9-71DE-48E6-9140-4AA1BF6C3568Q38202204-D1119E7A-46B9-4E09-8B47-0F07BA51CF0BQ38230326-77E39545-DEF9-4544-87DD-D1278530DCA9Q38504083-DF4F6ECA-8DA0-4A37-B165-7595A123965BQ38866094-257F6875-559F-405C-8619-E6D6F8005E3BQ39197535-A1D9C60E-0419-4059-A739-FAE0AF3D6168Q39779573-BCCE379A-1B7C-4D49-850D-160077637C7FQ40456177-DA5D56C3-2CA2-49FA-974E-C46995F909E6Q40582535-14F9677F-122B-45B6-9643-EB2132F30E2DQ41604021-EF474210-C070-4396-9EF1-B76EE7B8CD70Q41645585-EC06BFAD-EC0C-4922-BB26-66C8AB88D6C7Q42243338-8AB55231-3A4C-4497-80D9-F8E97569AD6EQ42362452-F4FF6F05-C159-4118-8756-13C6AFF30CB3Q46964196-D83A2F66-E775-4D66-B591-0E983737CC6CQ47930594-68BC0212-CB1C-4B26-ABFB-537B64B98663Q47997702-8718CDEA-E90E-4BD4-A617-02A49481E62DQ50527118-4C486D59-A415-4051-8E8A-CB2C21C34DD1Q52673481-902FF9F9-7CDD-4C9C-A807-36B298496C62Q52731268-208A82C4-4678-424B-8F82-8AB14816C8DEQ53119464-60300A8D-8769-4215-B0DF-DE9C1FB71D6CQ53801840-F4BD127C-9AD0-45F4-8AA7-46E2E6FE8D2CQ54647310-F72B5353-54D6-47CE-B0FF-B157C6F34EA9
P2860
Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Diagnosis and classification o ...... cell hematopoietic neoplasms.
@ast
Diagnosis and classification o ...... cell hematopoietic neoplasms.
@en
type
label
Diagnosis and classification o ...... cell hematopoietic neoplasms.
@ast
Diagnosis and classification o ...... cell hematopoietic neoplasms.
@en
prefLabel
Diagnosis and classification o ...... cell hematopoietic neoplasms.
@ast
Diagnosis and classification o ...... cell hematopoietic neoplasms.
@en
P2093
P1476
Diagnosis and classification o ...... t cell hematopoietic neoplasms
@en
P2093
Hans-Peter Horny
Lawrence B Schwartz
Wolfgang R Sperr
P304
3-11; quiz 12
P356
10.1016/J.JACI.2004.02.045
P407
P50
P577
2004-07-01T00:00:00Z